12 fundamentally screened watchlists × 10 setups each = 120 high-conviction recovery plays across SaaS, Fintech, Cybersecurity, AI, China Tech, Large Cap, Europe, Shortage, Crypto, Micro/Nano, Quantum & Top Picks.
Every pick in these 12 watchlists has been fundamentally screened: we eliminated tickers with declining revenue, negative gross margins, zero revenue, and excessive short interest (>15%). Remaining picks are ordered by conviction. Risk levels: LOW = profitable, <10% short, MEDIUM = near-profitable or cyclical, HIGH = early-stage growth, EXTREME = pre-revenue/speculative. Size accordingly: 2-3% for Low/Medium, 1% max for High/Extreme. Use stop losses. Scale in over 2-4 weeks.
Strait of Hormuz tensions entering 2nd week. Oil spiking. Supply chain disruption fears spreading to Asia-Pacific shipping lanes.
February NFP printed at just 28K vs 130K consensus. Unemployment ticked up to 4.2%. Labor market cracking under pressure.
DeepSeek R2 launch crushed AI valuations. Market repricing entire AI stack as open-source models commoditize inference.
25% tariffs on Canada/Mexico + 20% on China effective. Retaliation cycle accelerating. Supply chains disrupted globally.
BTC -35% from $100K+ highs. Altcoins decimated. Risk-off contagion spreading from speculative assets to growth equities.
"The BofA Bull & Bear Indicator has dropped to 2.1 — a level that has historically triggered contrarian buy signals with 85% hit rate over the following 3 months. The last time it was this low was October 2022, right before a 25% rally."
| Quarter | Actual EPS | Est. EPS | Surprise |
|---|---|---|---|
| Q1 2025 | $1.26 | $1.20 | +5.0% |
| Q2 2025 | $1.70 | $1.29 | +31.8% |
| Q3 2025 | $6.80 | $1.59 | +327.7% |
| Q4 2025 | $1.59 | $1.68 | -5.4% |
| Quarter | Actual EPS | Est. EPS | Surprise |
|---|---|---|---|
| Q1 2025 | $0.61 | $0.55 | +10.9% |
| Q2 2025 | $0.94 | $0.72 | +30.6% |
| Q3 2025 | $0.85 | $0.76 | +11.8% |
| Q4 2025 | $0.69 | $0.78 | -11.5% |
| Quarter | Actual EPS | Est. EPS | Surprise |
|---|---|---|---|
| Q1 2025 | $0.30 | $0.17 | +76.5% |
| Q2 2025 | $0.36 | $0.25 | +44.0% |
| Q3 2025 | $0.52 | $0.42 | +23.8% |
| Q4 2025 | $0.50 | $0.46 | +8.7% |
| Quarter | Actual EPS | Est. EPS | Surprise |
|---|---|---|---|
| Q1 2025 | $0.83 | $0.91 | -8.8% |
| Q2 2025 | $0.84 | $0.88 | -4.5% |
| Q3 2025 | $0.76 | $0.95 | -20.0% |
| Q4 2025 | $0.77 | $0.81 | -4.9% |
| Quarter | Actual EPS | Est. EPS | Surprise |
|---|---|---|---|
| Q1 2025 | $0.31 | $0.30 | +3.3% |
| Q2 2025 | $0.41 | $0.44 | -6.8% |
| Q3 2025 | $0.35 | $0.39 | -10.3% |
| Q4 2025 | $0.69 | $0.49 | +40.8% |
| Quarter | Actual EPS | Est. EPS | Surprise |
|---|---|---|---|
| Q1 2025 | $8.41 | $7.09 | +18.6% |
| Q2 2025 | $4.97 | $3.56 | +39.6% |
| Q3 2025 | $3.73 | $2.89 | +29.1% |
| Q4 2025 | $0.57 | $0.67 | -14.9% |
| Quarter | Actual EPS | Est. EPS | Surprise |
|---|---|---|---|
| Q1 2025 | $1.33 | $1.16 | +14.7% |
| Q2 2025 | $1.40 | $1.30 | +7.7% |
| Q3 2025 | $1.34 | $1.21 | +10.7% |
| Q4 2025 | $1.23 | $1.29 | -4.7% |
| Quarter | Actual EPS | Est. EPS | Surprise |
|---|---|---|---|
| Q1 2025 | $1.65 | $1.44 | +14.6% |
| Q2 2025 | $1.76 | $1.69 | +4.1% |
| Q3 2025 | $1.85 | $1.74 | +6.3% |
| Q4 2025 | $1.93 | $1.72 | +12.2% |
| Quarter | Actual EPS | Est. EPS | Surprise |
|---|---|---|---|
| Q1 2025 | -$0.12 | -$0.12 | In Line |
| Q2 2025 | -$0.13 | -$0.20 | +35.0% |
| Q3 2025 | -$0.10 | -$0.16 | +37.5% |
| Q4 2025 | $0.09 | $0.02 | +350.0% |
Lower beta, proven profitability, dividend income. Max 2% per position.
Total exposure: 9% | Avg Beta: 0.94 | Yield: ~1.8%
Mix of quality and growth. Max 2.5% per position. Scale in over 2 weeks.
Total exposure: 14.5% | Avg Beta: 1.10
Full conviction. Max 3% per position. Scale in over 3-4 weeks. Expect volatility.
Total exposure: 23% | Avg Beta: 1.28 | Max single: 3%
One of the most dangerous phrases in investing is "buy the dip." Without a framework, it degenerates into catching falling knives. Here is how professional traders distinguish between the two.
A genuine "dip" occurs when a fundamentally strong asset drops temporarily due to macro fear, sector rotation, or short-term noise — not because of deteriorating business quality. The key: the company's competitive position, revenue trajectory, and balance sheet remain intact. You are buying a $100 bill for $60 because the market is panicking. Example: SAP down 35% despite 4/4 earnings beats — the business did not break, the market's risk appetite did.
A falling knife is when a stock drops because the fundamentals are genuinely deteriorating — revenue declining, margins compressing, debt spiraling, management losing credibility. The stock looks "cheap" on trailing metrics but is actually expensive on forward estimates that are being revised down. Classic example: buying WeWork at $5 because it was once worth $47B. The price was lower, but the value was lower still. The key distinction: is the business getting worse, or is the price getting cheaper while the business stays the same?
Before buying any oversold stock, run through this checklist: (1) Revenue still growing or stable? (2) Balance sheet strong (cash > debt or manageable leverage)? (3) Insider buying or at least not selling? (4) Analyst consensus not deteriorating sharply? (5) Competitive moat intact? If 4/5 are yes, it is a dip. If 2 or fewer are yes, it is a knife. All 10 picks in today's report score 4/5 or 5/5.
Even if you correctly identify a dip, sizing matters enormously. The golden rules: never allocate more than 3% of your portfolio to a single oversold name, scale in over 2-4 weeks (do not deploy all capital on day 1), always use stop losses (typically 15-20% below entry for oversold setups), and keep total "blood in the streets" exposure below 25% of your portfolio. The remaining 75% should be in index funds, cash, or quality names at fair value. This is about asymmetric risk/reward, not gambling.
Studies from BofA, JPMorgan, and Goldman Sachs show that buying stocks down 50%+ from highs, when filtered for quality (profitable, growing, low debt), has produced average 12-month returns of +65% since 1990. The win rate is approximately 72%. However, without the quality filter, the win rate drops to just 45%. The filter is what separates dip buying from knife catching. Today's 10 picks all pass the quality filter — that is the edge.
This report is produced by Market Watch for informational and educational purposes only. It does not constitute investment advice, a solicitation, or a recommendation to buy or sell any securities. All investments involve risk, including the possible loss of principal. Past performance does not guarantee future results.
The "Blood in the Streets" picks are selected based on quantitative screening and qualitative analysis, but there is no guarantee that any of these positions will be profitable. Deeply oversold stocks can continue to decline. Always do your own due diligence, consult a licensed financial advisor, and never invest more than you can afford to lose.
Market Watch, its authors, and contributors may hold positions in some of the securities mentioned. Data sourced from MarketWatch Gateway, Yahoo Finance, Bloomberg, and public filings as of March 7, 2026. All prices are closing prices as of March 6, 2026 or most recent available.
Sources: MarketWatch Gateway (real-time data), Yahoo Finance (fundamentals), Bloomberg (analyst consensus), SEC EDGAR (filings), Bank of America Global Research (Bull & Bear Indicator), Silver Institute (supply/demand data), COMEX (inventory data), US Department of Defense (rare earth contracts).